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ANTIBACTERIAL PROPERTIES OF CROTON SPECIES    
ABSTRACT                                                
Natural substances of botanical origin have been important in African traditional medical 
practice. They have been used for various illnesses such as infections. Infectious diseases 
caused by pathogenic bacteria affect many communities and the treatment is made difficult 
partly because of antibiotic resistant strains. Phytochemicals isolated from medicinal plants 
are known to be effective in treating bacterial infections. Species under Croton genus are 
found in the different parts of the world and are widely used for the treatment of bacterial 
infections. The objectives of the study were to evaluate antibacterial properties and 
synergistic effects on antibiotic treatments of Croton species. 
 
Electronic database MEDLINE was searched for studies from January 1990 to November 
2011 on antibacterial properties of extracts of Croton species against different bacterial 
strains. Ten articles, with twelve species of Croton, filled the inclusion and exclusion criteria. 
The following Croton species were used in the studies: C. megalobotrys C. steenkapianus, C. 
silvaticus, C. pseudopulchellus, C. zambesicus, C. macrostachyus, C. tiglium, C. campestris, 
C. zehntneri, C. cajucara, C. urucurana and C. sonderianus. 
                                                                         
In these articles organic solvents (methanol, ethanol, acetone and hexane), inorganic solvents 
(water) and hydrodistillation were described for extraction. From different Croton species 
different methods were used to extract the active contents from roots, leaves, stem-bark and 
seeds. The resulting extracts and fractions of the extracts were tested against nine Gram 
negative and eleven Gram positive bacteria in addition to sensitive and resistant strains of 
Mycobacterium tuberculosis using different antibacterial tests. The antibacterial properties 
were quantitatively evaluated by the minimum inhibitory concentration (MIC), the minimum 
inhibitory dose (MID) and the zone of inhibition (ZH).  
                                                                                                            
Organic extracts were effective growth inhibitors of Gram negative and Gram positive 
bacteria. In addition, they enhanced the effectiveness of specific antibiotics. Water extracts 
were inactive against M. tuberculosis strain, which was sensitive to streptomycin, isoniazid, 
ethambutol and rifampin. Essential oils from certain species of Croton were not only 
effective against tested bacterial strains, but they enhanced the antibiotic activities of the 
drugs used in the studies.   
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Extracts of Croton species can be used as an alternative means of treating bacterial infections 
and could be possible to use as an adjuvant in antibiotic therapy against pathogenic bacterial 
infections.  
                                                                                                                                    
Further studies including the use of animal models are required to investigate the activities of 
the active compounds. Toxicological evaluation of the Croton species is also needed.  
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1. INTRODUCTION 
 
Many communities in Asia, Africa and South America have used medicinal plants for the 
treatment of diseases for centuries. These substances have been used for various illnesses 
such as infections. Microorganisms especially bacteria can be found in almost everywhere 
and have the tendency to adapt quickly to their immediate environment. Infections caused by 
bacteria are responsible for considerable mortality and morbidity worldwide especially in 
developing countries due to poor sanitation, unhygienic and overcrowded living conditions. 
Drugs for treating bacterial infections may lose their effectiveness with time, because the 
targets of these drugs keep shifting their forms. The time period for developing new drugs are 
often long and hence drug resistance take place (Theuretzbacher 2011). 
                                                                                                                                                                                                           
The increasing global trend of resistance to drugs among Gram-positive and Gram negative 
bacteria pose major challenges to health care workers (Bassetti et al. 2011). Multidrug 
resistant bacteria are resistant to several different antibiotics. The management of multi-drug 
resistant bacterial strains is difficult because treatment options are limited and if available are 
beyond the reach of the poor. This may increase risks of death, increase length and the cost of 
hospitalization and increase the cost on healthcare systems (Miyakis et al. 2011). There is 
urgent need to explore new effective areas for the treatment of infectious diseases (Aiyegoro 
et al. 2011).     
 
Currently, studies on herbal medicines appear under different names, such as plant medicines, 
phytomedicines, natural products and under pharmacognosy usually referring to products 
processed from living organisms: plants, animals, insects, microorganisms and marine 
organisms. Atropine, morphine, quinine, ephedrine, warfarin, salicin, digoxin, vincristine, 
taxol, and hyosine are some examples of extracts from traditional plants currently used in 
modern medicines. Findings from ethnobotanical and ethnomedicinal studies have shown 
correlation between medicinal use and laboratory results. Natural sources are usually the 
starting points for most pharmacological agents (Liu 2011). 
                                                                                                                               
Owing to the continuous development of antibiotic resistant strains, screening of plant 
materials and plant extracts for new antimicrobial compounds represent a significant source 
of new and effective medicine.    
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Reasons for the use of traditional medicines may vary, beside the fact that the plant 
preparations are relatively cheaper, adverse drug reactions (ADR) are rarely observed when 
compared with synthetically produced pharmaceuticals (Chariandy et al. 1999).                                 
Antibacterial effects against certain resistant infectious pathogens are profound and effective 
if combinations of different plant extracts are used (Nascimento et al. 2000).  Various studies 
have established that herbal medicines can be developed as safe, effective and less costly 
alternatives to the current medicines to the treat certain bacterial infections (Vermani and 
Garg 2002). 
 
Croton can be a tree, shrub or herbaceous plant which grows in tropical and warm regions. 
Some of the most popular uses include treatment of cancer, constipation, diabetes, digestive 
problem, dysentery, external wounds, intestinal worm, pain, ulcers and weight loss. Several 
Croton species are characterized by the presence of red sap (Salatino et al. 2007).  
 
2. JUSTIFICATION OF THIS STUDY 
 
There are limited reviews on the antibacterial properties of Croton species: the efficacy of the 
extracts, pharmacology and phytochemistry. The Croton species are found in different parts 
of the world and are known for their medicinal properties. Popular uses of Croton include 
treatment of malaria, fever, external wounds, dysentery, digestive problems, 
hypercholesterolemia, hypertension, intestinal worms, pains, ulcers and weight loss. Some 
species of Croton are known to contain proanthocyanidins or alkaloids.  These alkaloids may 
be in the form of taspine or some of the several benzylisoquinoline-like compounds. 
Diterpenes a common compound in Croton may be represented as clerodanes, cembranoid, 
halimanes, kauranes, labdanes, phorbol esters, trachylobanes and sarcapetalanes. Volatile oils 
are present in some of the Croton species (Salatino et al. 2007).  Some of these compounds 
present in Croton species have been shown to have antibacterial properties (Peres et al. 1997, 
Abo et al. 1999). Evidence from in vitro studies point to the use of essential oils as 
antibacterial agents for wide range of pathogenic bacteria strains such as Listeria 
monocytogenes,  Listeria innocua, Salmonella typhimurium, E. coli, Shigella dysenteria, 
Bacillus cereus, Staphylococcus aureus and Salmonella typhimurium (Burt 2004, Nguefact et 
10 
 
al. 2004, Schmidt et al. 2005).   Biologically active compounds such as sonderianin, korberin 
A and B isolated from the genus Croton with specific antibacterial activities against 
Mycobacterium smegmatis, Staphylococcus aureus, Bacillus subtilis, E. coli (McChesney et 
al. 1991) are however well known. Compilations of information on the antibacterial activity 
and synergistic effects of extracts and essential oils from Croton species and the biologically 
active compounds responsible for these antibacterial activities will be justified. 
 
3. OBJECTIVES 
 
- To evaluate the antibacterial properties of the extracts from different Croton species. 
- To assess the synergistic effects of the extracts from Croton species on antibiotic 
activities. 
- To identify the biologically active compounds present in the different parts of the 
Croton plants used. 
 
4.  METHODS 
4.1. Search strategy  
 
The search was done on November 2011. PubMed was used as the sole electronic database 
for searching the articles. The language was limited to English and the years from 1990 to 
2011. The following key words were used; “Croton”, “Croton and antibacteria”. The articles 
were examined either they met the inclusion criteria or not.  
The first selection was made based on the titles of the articles and the articles with the 
relevant titles were selected. Subsequently, the abstracts were read and those that were in line 
with the inclusion criteria were selected. 
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4.2. Inclusion criteria 
 
The studies included were either in vivo or in vitro studies carried out with a human bacterial 
pathogen. All the species under the genus Croton were selected. Studies on the Croton 
extracts tested against viruses, fungi, protozoa and parasitic infections were not included. 
Extracts from the Croton species should have been used alone or in combination with other 
plants. The studies should be based on experiments, any reviews or meta-analyses were 
rejected.  
 
 
4.3. Data analysis 
 
 
The results are described in the narrative and collected in the tables, because of the various 
methodologies used in the studies.   
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5. RESULTS 
5.1. Outline of the included studies  
 
Using Pubmed as the sole electronic data base, 1795 articles on Croton were identified. 
Further searches on Croton spp. and antibacterial agents generated 53 articles. When the 
studies were limited from 1990 to 2011, 27 articles were produced. All of the 27 articles were 
read. After excluding those studies that did not fulfill the inclusion criteria, 10 studies were 
included in this review.  
 
 
 
 
 
 
 
 
 
  
                                                                                              
Fig. 1. Flow chart of literature search 
 
 
 
 
 
1795 related titles on 
Croton spp were 
identified 
Croton spp and 
antibacterial agents 
generated 53 articles 
27 full articles retrieved   
10 studies were used for the 
review  
1742 titles were eliminated because 
they were used for other purposes 
other than as antibacterial agents or 
the antibacterial properties were 
reported by indigenous people not 
verified by experimental work 
26 articles were excluded after the 
period of the studies were limited from 
1990 to 2011   
17 studies were excluded because the 
extracts from a particular portion of the 
Croton were not tested against human 
bacterial pathogens 
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5.2. Characteristics of the included studies 
 
5.2.1. Croton species 
 
The genus Croton belongs to the subfamily Crotonoideae of family Euphorbiaceae, one of the 
largest families of plants, often characterized by being monoecious. The predominant genera 
under the Euphorbiaceae family are Drypetes, Jatropha, Macaranga, Croton, Euphorbia, 
Acalypha, Glochidion and Macaranga. 
 
The genus Croton has about 1300 species of trees, shrubs and herbs and is found in the 
tropical and subtropical regions of North and South Hemispheres. A number of the Croton 
species are known for their medicinal qualities especially in Africa, Asia and South America. 
Croton has been found to possess secondary metabolites such as alkaloids, terpenoids, 
flavanoids and compounds such as diterpenoids. Croton spp. are commonly used for the 
treatment of non communicable diseases such as diabetes, cancers and other ailments such as 
digestive problems, dysentery, wounds, fevers, constipation, diarrhea, intestinal worms, 
malaria, pain ulcers, inflammation. The parts that are used for the treatments of the different 
kinds of disease are the leaves, the roots, the stem barks, the fruit and the seeds (Yibralign 
2007). 
 
The Croton spp. used for this review are found in different regions; C. megalobotrys C. 
steenkapianus, C. silvaticus (Matias et al. 2011) and C. pseudopulchellus in South Africa; C. 
zambesicus (Abo et al. 1999) in Nigeria; C. macrostachyus (Wagate et al. 2010), in Kenya; C. 
tiglium (Shalid et al. 2008) Pakistan; C. campestris (Matias et al. 2011), C. zehntneri 
(Rodrigues et al. 2009), C. cajucara (Alviano et al. 2005), C. urucurana (Peres et al. 1997); 
and C. sonderianus (McChesney et al. 1991) in Brazil. 
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Fig. 2. The picture above is C. macrostachyus  one of the Croton species. Photographied by 
Jackie Obey  in “Nature Preserve” of  the campuses of University of Eastern Africa, Baraton 
Kenya.  
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Table 1. Information on the various species of Croton 
 
 
 
Author(s) 
 
Croton spp. 
 
Location of the 
plant species 
 
Plant 
identification  
 
Local 
name(s)/ 
vernacular 
name(s) 
 
Traditional use 
 
Matias et 
al. 2011 
 
C. campestris 
 
Municipality 
of Crato, 
Ceara, Brazil 
 
Herbario da 
Universidade 
Federal do 
Rio Grande 
do Norte 
 
Velame do 
campo 
 
Depurative 
against 
scrophulosis, 
venereal 
diseases, skin 
diseases, 
rheumatism, 
ulcers, tumors  
 
Selowa et 
al. 2010 
 C. 
megalobotrys 
 C. 
steenkapianus 
 C. silvaticus 
Lowveld 
National 
Botanical 
Garden in 
Nelspruit, 
South Africa. 
Lowveld 
national 
Botanical 
Garden staff 
N/A Use as 
purgative 
 
Rodrigues 
et al. 2009 
 
C.  zehntneri 
 
Cranto county, 
Ceara State, 
Brazil 
 
Da‟rdano 
Andrade 
Lima 
Herbarium, 
University of 
Regionaldo 
Cariri -  
URCA.  
Brazil 
 
N/A 
 
Sedative, 
appetite 
stimulating 
antianorexigen, 
relief of 
gastrointestinal 
disturbances 
 
Shalid et al. 
2008 
 
C.  tiglium 
 
Punjab 
Agriculture 
College 
 
Department 
of Botany, 
University of 
Agriculture, 
Faisalabad, 
Pakistan 
                          
N/A 
 
Use as 
purgative and 
antispasmodic  
 
Alviano et 
al. 2005 
 
C. cajucara 
 
Embrapa 
Experimental 
Farm, 
Amazonas, 
Brazil 
 
Embrapa 
Experimental 
Farm, 
Amazonas, 
Brazil 
 
N/A 
 
 
Antileishmanial  
activity 
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Table 1 continued  
NA: Not available  
 
Reference 
 
Croton spp. 
 
Location of 
the plant 
species 
 
Plant 
identification  
 
Local 
name(s)/ 
vernacula
r name(s) 
 
 
Traditional 
uses 
 
Lall and 
Meyer 
1999 
 
 
C.  
pseudopulchellus 
 
South and 
Central parts 
of South 
Africa (Lady 
Grey, Aliwal 
North, Elliot, 
Berkley 
East, 
Durban, 
Umalazi) 
 
HGWJ 
Schweicherdt 
Herbarium of the 
University of 
Pretoria and the 
Herbarium of the 
National 
Botanical 
Institute, 
Pretoria, South 
Africa 
                  
N/A 
 
TB symptoms 
such as 
coughs, fever, 
blood in 
sputum 
Abo et al. 
1999 
C. zambesicus 
 
Collection 
was done in 
Ibadan, 
Nigeria 
Forestry 
Research 
Institute of 
Nigeria 
„Iyeye‟, 
„Ajekofol
e‟ 
Typhoid, 
diarrhoea, 
dysentery 
 
 
Peres et al. 
1997 
 
C.  urucurana 
 
Dourados 
MS, Brazil 
 
Herbarium of the 
Centro de 
Ciencias 
Biologicas e da 
Saude, Campo 
Grande MS 
Brazil 
 
 
Sangra 
d‟agua 
(Dragon‟
d blood) 
 
Wound 
infections, 
celearte 
wound 
healing, 
rheumatism, 
cancer 
McChesney 
et al. 1991 
C.  sonderianus Sobral, 
Ceara, Brazil 
Herbarium of the 
Botanica, 
University of 
Ceara. Brazil 
 
Marmelei
ro preto 
Gastric 
diseases 
Wagate et 
al. 2010 
C.  
macrostachyus 
Machakos 
and Kitui 
regions of 
Eastern 
Kenya 
Department of 
Land and 
Resource 
management and 
Agricultural 
Technology, 
University of 
Nairobi, Kenya 
 
Mukambi 
/Kitundu 
Typhoid and 
measles 
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5.2.2. Parts of the Croton plants used for the experiments 
 
Efficacy of biologically active compounds in plant extracts against bacterial pathogen 
depends on factors such as region where the species is found, the time period within which 
the plants parts were collected and the storage condition (Taniguchi and Kubo 1993). 
Different parts of plants Croton spp. plants have their typical compounds; saponins and resins 
are usually found in the seeds (PROTA 2011) crotepoxide and crotomacrine in fruits (Tane et 
al. 2004). Stem barks and twigs contain fatty acids, lupeol, betulin (PROTA 2011), roots 
contain chalcone and secondary metabolites such as 3β-acetoxy tetraxer-14-en-28-oic acid, 
trachyloban-19-oic acid, trachyloban-18-oic acid, neoclerodan-5,10-en-19,6β; 20,12-diolide, 
3α,19-dihydroxy trachylobane, 3α,18,19-trihydroxy trachylobane (Kapingu et al. 2000). 
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Table 2. Parts of Croton species used in the studies  
Croton species Part of the plant used in the 
studies  
 
C. macrostachyus 
 
Whole plant                              
Leaves                                              
Roots                                         
Bark                                         
Tuber 
 
C. sonderianus Roots 
 
C. zambesicus 
 
Leaves 
Stem bark 
 
C. pseudopulchellus 
 
Whole plant,                               
Stem bark 
Roots 
Leaves 
 
C. cajucara 
C. zehntneri 
C. steenkapianus 
C. silvaticus 
C. campestris 
 
 
Leaves  
 
C. tiglium 
 
Seeds 
 
C. urucurana 
 
 
Stem bark 
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5.2.3. Preparations of the various parts of the Croton species in the studies  
  
Different methods have been used for the preparation of the Croton plant material before the 
process of extraction takes place. Plant parts (whole plant, bark, root, leaves, tubers or a 
mixture of different parts) were chopped into smaller pieces air-dried at room temperature 
under shade and pulverized (Wagate et al. 2010). Similarly, stem bark of C. urucurana was 
air-dried at room temperature and pulverized (Peres et al. 1997). Roots of C. sonderianus 
were air-dried at room temperature and ground into powder (McChesney et al. 1991), in the 
case of C. cajucara leaves were coarsely ground into power after being dried at room 
temperature (Shalid et al. 2008). C. zambesicus was however oven-dried (Abo et al. 1999).  
 
5.2.4. Extraction  
 
Extraction with organic solvents 
 
Various extracts, organic and inorganic, at different concentrations, have been used to obtain 
the biologically active compounds present in the various parts of Croton plants. Most often 
organic solvents have been used for the extraction. In a study by McChesney et al. (1991), 
plant material was extracted using hexane, acid and neutral solvents. The extracted compound 
ent-beyer-15-en-18-oic acid and its derivatives such as ent-beyer-15-en-18-oic acid methyl 
ester; ent-beyer-15-en-18-ol; ent-beyer-15-en-18-al; and dihydro-ent-beyer-15-en-18-ol 
exhibited antibacterial properties.  In the study done by Peres et al. (1997), both methanol as 
the primary extract and n-hexane, n-hexane/dichloromethane, ethyl acetate and methanol as 
fractions of the primary extract exhibited antibacterial activities.  Studies by Shalid et al. 
(2008) used ethanol but at different concentrations for the extraction process. Experiment by 
Lall and Meyer, 1999, used acetone to extract plant material. In cases of Abo et al. (1990), 
Selowa et al. (2010), Matias et al. (2011), Wagate et al. (2010) methanol was used for the 
extraction processes.  
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Extraction with inorganic solvents 
 
In one study the use of water for extraction was reported. The water extract was prepared by 
boiling 20 grams of the aerial part of the plant material in 500 ml of distilled water under 
reflux and the extracts were dried. The residue was dissolved in water to a final concentration 
of 500 mg/ml (Lall and Meyer 1999). 
 
Extraction with other methods 
 
Two studies use hydrodistillation by the Clevenger apparatus to obtain oil from the leaves of 
C. cajucara (Alviano et al. 2005) and C. zehntneri (Rodrigues et al. 2009). Hydrodistillation 
in the case of C. zehntneri was followed by drying with anhydrous sodium sulphate to 
produce gaseous oil. 
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Table 3. Extracts and extraction methods used for the Croton species 
 
 
 
Reference 
 
Preparation 
if the plant 
material 
(into  a 
powder) 
 
 
Primary     
extracts 
 
Extraction 
process 
 
Secondary 
extracts 
 
Isolated 
compounds 
                                                    
C. campestris  
(Matias et al. 
2011) 
            
N/A 
                       
Methanol                              
Hexane  
                                            
N/A
                                      
N/A 
                                
N/A 
 
C. 
megalobotrys 
(Selowa et al. 
2010) 
                                         
C.  
steenkapianus 
(Selowa et al. 
2010) 
C. silvaticus  
(Selowa et al. 
2010)                                 
 
N/A 
 
 
 
N/A 
 
 
                     
N/A 
 
Methanol                                            
n-Hexane    
         
 
Dichloromethane                         
Ethyl acetate                         
Acetone 
      
 
N/A 
                               
 
N/A
 
 
 
N/A 
 
 
 
N/A 
 
Chloroform                                      
n-Hexane  
      
 
Carbon 
tetrachloride                
Butanol                                     
                                 
N/A 
 
 
 
N/A 
                               
C. zehntneri 
(Rodrigues et 
al. 2009) 
                       
N/A 
                              
N/A 
  
Hydrodistillation 
                             
N/A 
                        
N/A 
                              
C. tiglium 
(Shalid et al. 
2008) 
                     
N/A 
                   
Ethanol 
                                  
N/A N/A 
                       
Ct-50 
(purified    
protein) 
                             
C. cajucara 
(Alviano et 
al. 2005) 
             
Coarsely 
grounded 
into a 
powder, 
dried at RT 
                                   
N/A 
     
Hydrodistillation 
                             
N/A 
                
Linalool                                 
Purified 
linalool 
 
                                                                                                                                                                          
N/A:  Not available, RT: Room temperature 
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  Table 3 continued 
 
 
Reference 
 
Preparation 
if the plant 
material 
(into a 
powder) 
 
 
Primary 
extracts 
 
Extraction 
process 
 
Secondary 
extracts 
 
Isolated 
compounds 
 
C. 
pseudopulchellus 
(Lall and Meyer, 
1999) 
 
N/A 
 
Acetone          
Water 
 
N/A 
 
N/A 
 
N/A 
C. zambesicus 
(Abo et al. 1999) 
N/A Methanol N/A N/A N/A 
C. urucurana 
(Peres et al. 
1997) 
Air-dried 
at RT and 
pulverized. 
Aqueous 
ethanol 
N/A n-Hexane                    
n-Hexane/ 
dichloro 
methane     
Ethylacetate   
Methanol 
Acetyl-aleuri- 
tolic acid                           
β-Sitosterol-
O-
gasslucoside 
Sonderianin               
β-Sitosterol 
Campesterol    
Catechin 
Gallocatechin 
 
C. sonderianus 
(McChesney et 
al. 1991) 
 
Air-dried 
at RT, 
ground 
into a 
powder 
 
 
Hexane 
 
N/A 
 
Neutral fraction 
Acidic fraction 
 
N/A 
C. 
macrostachyus 
(Wagate et al. 
2010) 
Chopped, 
air-dried at 
RT under 
shade, 
pulverized  
Methanol N/A N/A N/A 
 
   N/A:  Not available, RT: Room temperature 
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5.3. Studied bacteria used for the experiments 
 
Different bacteria were used in the referred studies they were: Bacillus subtilis, 
Staphylococcus aureus, E. coli, Pseudomonas aeruginosa, Mycobacterium smegmatis, 
Salmonella typhimurium, Mycobacterium tuberculosis, Salmonella typhosa, Shigella 
dysenteriae, Klebsiella pneumoniae, Proteus mirabilis, Bacillus megaterium, Lactobacilus 
casei, Streptococcus sobrinus, Streptococcus mutans, Porphyromonas gingivalis, 
Pasturella multocida, Enterococcus faecalis, Micrococcus lutea, Bacillus cereus.  
 
For infections to occur, bacterial adhesion is required as well as the host cell surface 
carbohydrates, which serve as receptors for adhesion. Adherence of bacterial cells to 
specific receptors such as glycoconjugates and extracellular matrix molecules prevents 
dislodgement by the host mucociliary defense mechanisms and aid bacterial invasion into 
cells (Kouki et al. 2011).  E. coli P fimbrial adhesins bind to the galactosyl-1–4-galactose 
(Galα1-4Gal) in the host receptor cells.  Thus E. coli causes many infectious diseases in 
human such as urinary tract infections (Dodson et al. 2001) and common intestinal diseases 
(Matias et al. 2011). 
 
The genus Staphylococcus is distributed in the environment and is often etiological agent 
for opportunistic infections in humans and animals. S. aureus, S. epidermidis, S. 
saprophyticus and S. haemolyticus are on top of the list of causative organisms of human 
and hospital infections. S. aureus is known to be the common etiological agent for purulent 
infections. E. coli, E. faecalis, S. aureus and P. aeruginosa as species of bacterial often 
involved in nosocomial infections (Verhoeff et al. 1999). 
 
According to Alviano and colleagues (2005), L. casei, S. aureus, S. sobrinus, P. gingivalis 
and S. mutans are generally associated with oral cavity disease.  These microorganisms 
occupy surfaces of teeth and below the gingival margins (Parsek et al., 2003; Wu et al., 
2002). The pathological states such as dental carries, periodontal diseases and tooth loss 
may eventually affect the overall health of the individuals (Socransky et al. 2002). 
Staphylococcus aureus and P. aeruginosa are known to be respiration tract bacterial 
pathogens. Sputum from patients with cystic fibrosis has been found to contain substantial 
amount of P. aureginosa and S. aureus (Coutinho et al. 2008, Valenza et al. 2008).  
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Tuberculosis caused by Mycobacterium tuberculosis (TB) affects close to 33% of the 
world‟s population. Individuals infected by human immunodeficiency virus (HIV) are 
susceptible to TB.  Majority of the incidents occur in Sub-Saharan Africa where in 2009 
1.7 million people were estimated to have died of the tuberculosis disease. 5-10% of 
individuals infected with TB bacilli develop the infection at a point in their lives. The 
treatment and control of tuberculosis have been increasingly difficult because the bacilli 
have developed resistance to antibiotics such as isoniazid and rifampicin (WHO 2011).   
 
5.4. Methods for testing the antibacterial properties  
 
For the antibacterial tests different methods have been used. McChesney et al. 1991 used 
the two-fold serial broth dilution assay for quantification of the antimicrobial activity. Lall 
and Meyer (1999) used the agar plate and radiometric methods. This method utilized 7H12 
Middlebrook TB medium with 
14
C-labelled substrate (palmitic acid) as a source of carbon. 
Abo et al. (1999) used the agar disc diffusion method to determine the antimicrobial 
activity of the Croton plant extracts. Shalid et al. (2008) reported that they used the disc 
diffusion method to determine the antimicrobial activity. Selowa et al. (2010) tested 
antibacterial activity of the Croton species employing the micro-dilution techniques on 96 
well micro-plates. 
                                                                                                        
In order to determine the antibacterial activity of the essential oil isolated from C. zehnteri, 
the two-fold serial dilution method was used. In the plate method bacterial organisms were 
innoculated into Petri dishes, which contained the nutrient agar. The antibiotic modifying 
activity of the volatile component of the essential oil was also assessed using the plate 
method. Antibiotic disks containing gentamycin and tetracycline were used to determine 
alterations in inhibition zone diameter against P. auriginosa (Rodrigues et al. 2009). 
 
 In studies carried out by Mathias et al. 2011, the antibacterial activity was assessed by 
using a microdilution assay. In the method certain amount of each bacterial strain was 
suspended in 96-well microtiter plate and titrated by using two-fold serial dilution method. 
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Antibacterial activity of the plant extracts against the reference bacterial strain was carried 
out using the broth dilution method in studies by Wagate et al. 2010.  The test organisms 
and the different methods used for the antibacterial tests have been collected in Table 4. 
 
Table 4. Test organisms and methods for antibacterial tests 
 
                                           
Reference 
                      Test organisms                                  
Method for 
antibacterial test Gram-negative 
bacteria 
Gram-positive 
bacteria 
                                                          
McChesney et al. 
1991 
E. coli                       
P. aeruginosa      
 
S. aureus                             
B. subtilis                   
M. smegmatis  
     
 
Two-fold serial broth 
dilution assay                                
 
Lall and Meyer, 
1999 
                                            
N/A 
                                                               
*
M. tuberculosis 
                                         
Plate method               
Radiometric method 
Abo et al. 1999 E. coli                               
S. typhosa                    
S. dysenteriae              
K. pneumonia                
P. mirabilis                 
P. aeruginosa                
S. aureus                          
B. subtilis                            
B. megaterium 
Agar disc diffusion 
method  
 
Shalid et al. 2008                                
 
P. multocida                                       
 
B. subtilis                                         
 
The disc diffusion 
method                                   
 
Selowas et al. 2010 
 
E. coli                              
P. aureginosa 
 
E. faecalis                              
S. aures                      
 
Micro-dilution 
technique with 96 
well micro – plates  
                                           
Rodrigues et al. 
2009 
                                            
P. aureginosa                      
                                                     
S. aureus  
                                                  
Serial dilution (two 
fold) 
 
Matias et al. 2011 
 
E. coli 
 
S. aureus 
 
Serial dilution (two 
fold) 
                              
Wagate et al. 2010 
                                     
                                   
E. coli                                    
P. aeruginosa                           
                                                 
                                  
M. lutea                                  
B. cereus                                         
                                    
Broth dilution 
method                                                   
 
                                                                                                                                               
Mycobacterium tuberculosis is neither Gram positive nor Gram negative bacteria, N/A: 
Not available.  
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The minimum inhibitory concentration (MIC), zone of inhibition (ZH) and minimum 
inhibitory dose (MID) were the commonly used measures of the antibacterial activity of 
the extracts and pure compounds against the selected bacterial organisms. Lall and Meyer 
(1999) simply defined MIC as the lowest concentration of drug that inhibited 99% of the 
growth of the bacterial population. Matias et al. (2011) defined MIC as the lowest 
concentration, where no growth was observed.  One study determined the antibacterial 
activity visually. MIC value was therefore taken as the lowest concentration of each of the 
substance at which turbidity was absent (Alviano et al. 2005). 
 
 The appearance of a clear zone around the growth bacteria indicated antimicrobial 
activity. The zone of inhibition (Shalid et al. 2008) was measured using a zone reader 
(Huynh et al. 1999). Studies by Abo et al. (1999) used the zone of inhibition measured 
manually in millimeters to express the antimicrobial activities of the plant extracts. 
 
McChesney et al. (1991) recorded the antimicrobial activity against B. subtilis as the width 
(millimeters) of the inhibitory zone (average radius) after incubating the bacteria for 24 
and 48 hours measured from the edge of the agar well to the edge of the inhibitory zone. 
The concentration of the compound in the first of the test tube that showed no visible 
growth after 24- and 48-hours incubation was taken as the MIC.  
 
The antibacterial and the synergistic effects of the volatile component of the essential oil 
extracted from C. zehntneri were expressed as the minimum inhibitory dose (MID). It was 
defined as the minimum inhibitory dose per unit space required to suppress the growth of 
microorganisms in a closed system (Rodrigues et al. 2009). MID values were given as the 
weight per volume of air (mg/L) (Inouye et al. 2001). Three studies (Wagate et al. 2010, 
Selowa et al. 2010, Peres et al. 1997) did not give specific definitions for the MIC but 
provided the general experimental procedures and values for the antibacterial activity of 
the plant extracts. 
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5.5. Antibacterial activity of organic extracts  
 
5.5.1. Antibacterial activity of the methanol extracts   
 
Wagate and colleagues (2010) found MICs between 15-250 mg/ml after testing methanol 
extracts of C. macrostachyus against four bacterial organisms. M. lutea was, however, not 
sensitive to methanolic extracts from the plant. Inoculum of 0.1mL in a test tube containing 
Muller Hilton broth was used as a negative control. As the positive controls, 
benzylpenicillin with MIC of 0.6mg/mL and streptomycin with MIC of 0.25mg/ml were 
used for Gram-positive and Gram negative bacteria, respectively (Wagate et al. 2010). 
 
When gentamicin, kanamycin and amikacin were used as antibiotics and tested against E. 
coli, MICs were 0.091, 0.157 and 0.157 mg/ml, respectively. When the methanolic Croton 
extracts were used alone, MIC value was 0.512mg/ml. Against S. aureus, gentamicin, 
kanamycin and amikacin gave MICs of 0.039, 0.317 and 0.078 mg/ml respectively. When 
methanolic Croton extracts were used alone, MIC of ≥1.024 mg/ml was achieved. Values 
shown in the table 7 indicate the MICs of the various combinations of drug-hexane extracts 
decreased MIC values for both S. aureus and E. coli (Matias et al. 2011).   
 
Results from Selowa et al. (2010) showed that, when tested against the different bacterial 
organisms, methanol extracts from the three Croton species: C. megalobotrys, C. 
steenkapiamus, and C. silvaticus produced different results. C. megalobotrys inhibited only 
E. coli and at higher concentrations, C. steenkapiamus inhibited P. auruginosa, but was 
inactive against E. coli, S. aureus and E. faecalis. In comparison, C. salvaticus inhibited 
weakly all the test organisms at the constant concentration of 1.25 mg/ml.  
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Table 5. Antibacterial activity of the methanol extracts from different Croton species 
expressed as MIC  
 
 
                                                                                                                                                                      
MIC: Minimum inhibitory concentration, N/A: Not active 
 
 
 
The figures in the table 6 show the zones of inhibition in millimeters of the methanol 
extracts of C. zambesicus against the tested bacterial organisms. Dilutions of each dried 
extract were prepared in 70% methanol to give final test concentrations of 100mg/ml, 
50mg/ml and 25mg/ml. For Gram positive and Gram negative bacteria 10µg/ml of 
gentamycin and 10µg/ml of ampicillin both in 70% methanol were used as the positive 
controls, respectively. When 70% of methanol was used as the negative control, no 
inhibition was observed. Methanol extracts from the stem bark had an overall better 
antibacterial activity values than methanol extracts from the leaves against P. aeruginosa 
and K. pneumonia, but had no inhibitory activities on S. typhosa and E. coli. The measured 
antibacterial activity of methanol extract of C. zambesicus against P. mirabillis, S. aureus, 
                               
Reference 
                                    
Croton species 
                         
Bacterial strain 
Antibacterial 
activity MIC 
(mg/ml) 
 
Wagate et al. 2010 
 
C.  macrostachyus  
                                      
M. lutea            
B. cereus              
E. coli             
P. aeruginosa  
                                           
N/A                                                  
15.6                                     
250                                    
250 
Selowa et el. 2010 C. megalobotrys 
 
 
 
                                               
C. steenkapianus 
 
 
                                                            
         
 C. silvaticus                                             
 
E. coli               
S. aureus        
E. faecalis       
P. aeruginosa 
E. coli               
S. aureus        
E. faecalis       
P. aeruginosa                                 
 
E. coli  
S. aureus        
E. faecalis       
P. aeruginosa 
1.25                                                       
0.625                           
0.02                          
0.313 
                                         
N/A                                           
N/A                                                                 
N/A                             
0.625
                                                    
1.25                                 
1.25                                       
1.25                           
1.25 
 
29 
 
B. megaterium and B. subtilis were comparable to that of ampicillin at 10µg/ml. Methanol 
extracts from the stem back of C. zambesicus produced similar results as gentamycin at the 
concentration of 10µg/ml (Abo et al. 1999) 
 
For C. campestris, the antibiotic activities were assessed using their respective MICs in the 
presence or absence of methanol and hexane extracts at the subinhibitory concentration of 
8 µg/ml. As the control, dimethyl sulfoxide (DMSO) was used. Table 7 shows the MICs of 
the extracts and extract-antibiotic combinations. 
  
For E. coli, MECC-antibiotic combination produced lower MIC values with the exception 
of gentamicin-MECC, and for HECC-antibiotic combination, the MICs were generally 
lower for all the antibiotics. In the case of S. aureus HECC-antibiotic combinations had 
MICs lower than antibiotics alone. E. coli showed greater sensitivity to the extracts than S. 
aureus but S. aureus exhibited greater sensitivity when antibiotics were combined with the 
extracts. The DMSO control produced the MIC of ≥1024 µg/ml and exhibited no antibiotic 
modifying activities (Matias et al. 2010). 
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Table 6. Antibacterial activity of C. zambesicus and reference antibiotics (10µg/ml) 
measured as zone of inhibition (ZH) (Abo et al. 1999) 
 
Bacteria    Dose (mg/ml)  ZH (mm) Antibiotic 
 Leaf   Stem bark  
 
P. aeruginosa 
 
100                  
50                    
25                                                                                                                                  
 
0                                         
0                                       
0
 
12                                       
10                                     
0 
                                                
0 (ampicillin)               
14 (gentamycin) 
S. dysenteriae 100                                     
50                                      
25 
10                              
7                            
0 
15                                       
13                                    
10 
                        
15 (gentamycin) 
 
S. typhosa 
 
100                                     
50                                      
25 
 
17                            
14                         
10 
 
14                                          
10                                       
0 
                     
 
18 (gentamycin) 
 
E. coli 
 
100                                     
50                                      
25 
 
16                     
13                        
10 
 
15                                    
12                                    
0 
                     
 
18 (gentamycin) 
 
K. pneumonia 
 
100                                     
50                                      
25 
 
0                            
0                           
0 
 
12                                   
10                                    
9 
                     
 
18 (gentamycin) 
 
P. mirabilis 
 
100                                     
50                                      
25 
 
9                          
7                           
7 
 
13                                    
11                                    
0 
                        
 
   12 (ampicillin) 
 
S. aureus 
 
100                                     
50                                      
25 
 
14                          
11                             
9 
 
16                                   
14                                     
10 
                      
 
12 (ampicillin) 
 
B. megaterium 
 
100                                     
50                                      
25 
 
12                           
10                          
7 
 
12                                  
10                                               
8 
                                         
 
10 (ampicillin) 
 
B. subtilis 
 
100                                     
50                                      
25 
 
 
10                                  
0                             
0 
 
11                                      
9                                       
7 
                                           
 
9 (ampicillin) 
                                                                                                                                                                             
0 - no inhibition 
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Table 7. MIC values (µg/ml) of aminoglycosides in the absence and presence of 8 µg/ml of 
MECC and HECC against E. coli and S. aureus (Matias et al. 2010)                                                                                                          
Antibiotic                  E. coli                S. aureus 
MIC alone     MIC combined    MIC alone     MIC combined 
    MECC HECC     MECC HECC 
Gentamicin 19      9 2.2     39      2.2  2.2 
Kanamycin 157    157 19     317     78   4.5 
Amikacin 157    9  39     78      9  4.5  
MECC 512    - -    ≥1,024      - - 
HECC 256    - -    ≥1,024      - - 
 
MECC: Methanol extracts of C. campestris, HECC: Hexane extracts of C. campestris, 
MIC: Minimum inhibitory concentration 
 
5.5.2. Antibacterial activity of the ethanol extracts   
 
In the ethanol extracts the appearance of clear zone was an indication of antibacterial 
activity. Table 8 shows different figures used to represent the extent of the activity 
measured in zone size: 0 mm, 1-5 mm, 6-15 mm and 16-25 mm, for no or poor activity, 
moderate activity, strong activity and very strong activity, respectively. Ciprofloxacin was 
used as the positive control and the negative control was autoclaved water. The ethanol 
extracts of C. tiglium strongly inhibited both P. multocida and B. subtilis. Ciprofloxacin 
inhibited strongly P. multocida and B. subtilis compared with autoclaved water, which had 
no antibacterial activity (Shalid et al. 2008).  
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Table 8. Antibacterial activity of the ethanol extracts and controls expressed as zone of 
inhibition (ZH) (Shalid et al. 2008)  
 
                             
Croton species 
   
Bacterial strain 
                             
ZH (mm) 
      Control                                             
Positive  Negative 
 
C. tiglium 
 
 
P. multocida  
B. subtilis 
 
6-15                                                                  
6-15 
 
16-25      
16-25 
 
NA
NA                                         
 
NA: no activity, ZH: Zone of inhibition 
 
 
According to Peres et al. (1997), the aqueous ethanolic, n-hexane and n- hexane/ 
dichloromethane extracts of C. urucurana exhibited better antibacterial activity against S. 
aureus than against S. typhimurium (table 9). The n-hexane/dichloromethane extracts 
showed the highest inhibitory activity against S. aureus with MIC value of 0.8mg/ml 
followed by aqueous ethanol extracts with MIC value of 2mg/ml and n-hexane with MIC 
value of 3.5 mg/ml. S. typhimurium was resistant to the aqueous ethanolic extracts and all 
activity with MIC values of 4-6 mg/ml.  
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Table 9. Antibacterial activity of the ethanol extracts and fractions of C. urucurana 
expressed as MIC (Peres et al. 1997) against S. aureus and Salmonella typhimurium 
 
Extracts  
                                        
                                     MIC (mg/ml) 
 
  
S. aureus  
 
Salmonella typhimurium  
 
                                                       
Aqueous ethanolic  
                                                            
2 
 
5 
n-Hexane 3.5 6 
n-Hexane/dichloromethane 0.8 4 
Ethyl acetate  4.0 4 
Methanol 5.0 5 
 
 
MIC: Minimum inhibitory concentration  
 
5.5.3. Antibacterial activity of hexane extracts 
                                                                                                                                              
McChesney et al. (1991) tested hexane extracts from C. sonderianus against five bacterial 
strains to determine its antimicrobial activity. The zones of inhibition were put into 
different categories: no activity, 1-2 mm, 3-6 mm, 7-12 mm and greater than 13 mm of 
inhibition. The positive control was streptomycin sulfate at the concentration of 1mg/ml. 
Hexane extracts produced no inhibitory activity against E. coli but against B. subtilis the 
highest activity level of >13 mm was recorded. Against P. aeruginosa, S. aureus and M. 
smegmatis had activity of 7-12 mm.  Comparable results were obtained when streptomycin 
sulfate was used, however, M. smegmatis was the most sensitive strain.             
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Table 10.  Antibacterial activity of the hexane extracts and streptomycin sulfate expressed 
as the zone of inhibition (ZH) (McChesney et al. 1991) 
 
                                               
Croton species 
                                        
Bacterial strain 
                                                      
ZH (mm) 
Hexane 
extract 
Positive control 
 
C. sonderianus 
                                    
E. coli    
P. aeruginosa              
S. aureus                         
B. subtilis                          
M. smegmatis         
 
                                    
N/O                                                
7-12                                                      
7-12                                                       
>13                                               
7-12 
                                                               
7-12                                             
7-12                                                
7-12                                                   
7-12                                        
> 13 
 
ZH: Zone of inhibition, NO: No observed zone of inhibition.                                              
 
 
5.5.4. Antibacterial activity of the acetone extracts   
 
The proportion method referred also as the plate method proposed by Middlebrook and 
Cohn (1958) allows the determination of the proportion of bacterial population resistant to 
the plant extracts. A population is considered resistant when 1% or more of the 
microorganisms are resistance to a drug. The M. tuberculosis H37Rv strain was susceptible 
to several antibiotics: streptomycin, isoniazid, ethambutol and rifampin. Two dilutions 
from the sensitive strain (H37Rv) suspensions were made (1 ×10
-2 
mg/ml and 1 ×10
-4 
mg/ml). 0.2ml of 1 ×10
-2 
mg/ml H37Rv suspension was added to the plant extracts 
(acetone and water). For the two controls (medium + 1% DMSO), 0.2ml of 1 ×10
2 
mg/ml 
dilution and 0.2ml of 1 ×10
4
 mg/ml dilution
 
were added separately.  
 
The antibacterial activities were determined by comparing growth of bacteria in the 
medium with plant extract (marked as N
-2 
for 1 ×10
-2 
mg/ml dilution) to bacterial growth in 
the control (NO
-2 
for  1 ×10
-2 
mg/ml and NO
-4 
for 1 ×10
4
 mg/ml). The strain was 
considered resistant when N
-2 
> NO
-2
 sparingly susceptible when NO
-4 ≤ N-2 ≤ NO-2 and at 
N
-2 ≤ NO-4 the strain was considered sensitive (less than 1% growth). As shown in the table 
10, the MIC of acetone extracts of the areal parts of C. pseudopulchellus was 0.5mg/ml 
(Lall and Meyer 1999). 
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Table 10. Antibacterial activity of the acetone and water extracts of C. pseudopulchellus 
against H37Rv strain of Mycobacterium tuberculosis (MIC) using the agar plate method 
(Lall and Meyer 1999)                                                                                                               
  
                                               
Croton species 
                                  
Bacterial strain 
                                                             
MIC (mg/ml) 
Acetone 
extract 
Water extract 
C. pseudopulchellus H37Rv strain  0.5 NA 
 
MIC - Minimum inhibitory concentration, NA - not active, H37Rv - Antibiotic sensitive 
strain of M .tuberculosis.  
 
 
The radiometric method was used to confirm the results achieved from the agar plate 
method. This method is fast, reliable and convenient method for the determination of levels 
of antibacterial activities of drugs used against M. tuberculosis (Heifets et al. 1985). The 
plant extracts were tested against M. tuberculosis strain (CCKO28469V), which is resistant 
to two drugs (isoniazid and rifampin) and against the sensitive strain H37Rv susceptible to 
several antibiotics (streptomycin, isoniazid, ethambutol and rifampin). Antibacterial 
activities of the plant extracts were assessed at the concentrations of 1.0, 0.5 and 0.1 
mg/ml. Two vials without plant extracts were used as the controls. Values in the table 11 
indicate that, MICs for sensitive and resistant strains were 0.1 and 0.5 mg/ml, respectively. 
The changes in growth index (ΔGI) values, given as mean±SD, of the control vials were 
29±4.04 and 24±4.04 for the sensitive and resistant strains of M. tuberculosis, respectively 
(Lall and Meyer, 1999).       
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Table 11. Antimicrobial activity of the acetone extracts from C. pseudopulchellus on the 
growth of the strains H37Rv and CCKO28469V of Mycobacterium tuberculosis (Lall and 
Meyer, 1999) 
 
Bacterial strain MIC (mg/ml) ΔGI values (mean±SD) of plant extracts 
(mg/ml) 
Sensitive strain 
(H37Rv) 
0.1 2±0.5  
Resistant strain 
(CCKO28469V) 
0.5 1±1.1   
 
MIC:  minimum inhibitory concentration; ΔGI: Differences in the growth index values; 
SD:  standard deviation.  
 
5.6. Antibacterial activity of the inorganic extracts  
 
Lall and Meyer (1999) tested water extract of C. pseudopulchellus against a sensitive strain 
(H37Rv) of Mycobacterium tuberculosis. As seen in the table 10, water extract was 
inactive against the bacteria. 
 
5.7. Antibacterial activity measured by other extraction methods   
 
Hydrodistillation was used to extract oil from the leaves of C. zehntneri. The antibacterial 
activity of the essential oil was expressed as minimum inhibitory dose (mg/l air). From 
Table 12, P. aeruginosa showed resistance against the essential oil of C. zehntneri at all 
concentration used. S. aureus showed susceptibility at the concentrations 1 and 0.5 mg/l air 
(Rodrigues et al. 2009). 
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Table 12. Antibacterial activity of C. zehntneri essential oil assessed as MID (Rodrigues et 
al. 2009)  
 
Bacterial strain                                                   MID (mg/L air) 
 
1 0.5 0.25 0.125 0.0625 0.03125 
S. aureus -  -  + + + + 
P. aeruginosa + + + + + + 
 
+: growth observed; - : no growth observed; MID: minimum inhibitory dose. 
 
 
Using the plate method, the antibiotic modifying activity of volatile compound of C. 
zehntneri essential oil (CZEO) was determined. Two antibiotics, gentamicin and 
tetracycline were used against P. aeruginosa. There were two set of controls used: plates 
with antibiotic discs without essential oil and plates with DMSO alone (Rodrigues et al. 
2009). As seen from table 13, no significant changes in inhibition were observed for the 
controls. C. zehntneri essential oil (CZEO) enhanced the antibiotic activity of gentamicin 
by 42.8%; antibiotic activity of tetracycline plus CZEO remained unchanged (Rodrigues et 
al. 2009).                                                                                                                                       
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Table 13. Antibacterial modifying activity of C. zehntneri essential oil (CZEO) volatile 
compound assessed as mimimum inhibitory dose (MID 1 mg/L air) against P. aeruginosa 
(Rodrigues et al. 2009) 
 
Treatment                          ZH  
Gentamicin         
± SD 
Enhancement 
(%) 
Tetracyclin                
±SD 
Enhancement 
(%) 
No treatment 14±1.6 - 32±1.3 - 
DMSO 14±1.3 - 32.5±1.6 - 
CZEO 20±1.6 42.8 32±1.6 0 
 
CZEO: C. zehntneri essential oil, SD: Standard deviation, DMSO: dimethyl sulfoxide, ZH: 
Zone of Inhibition, - : no enhancement value provided. 
 
 
Hydrodistillation was also used to extract linalool-rich essential oil from C. cajucara 
(EOCC). The extracted essential oil inhibited the growth of the all tested bacterial 
organisms.  Table 14 shows the effects of EOCC on L. casei, S. aureus, S. sobrinus, P. 
gingivalis and S. mutans. The EOCC had higher activity than the standard drug 
chlorhexidine based on the MIC values. S. sobrinus was the most sensitive bacterial to 
EOCC (Alviano et al. 2005).    
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Table 14. Antibacterial activity of linalool rich essential oil from C. cajucara represented 
as MIC values (mg/ml) (Alviano et al. 2005)      
 
                                  
                               MIC 
Bacterial strain Linalool-rich EOCC 
 
*Chlorhexidine 
 
L. casei 
 
22.3 
 
36.5 
S. aureus 33.4 40.5 
S. sobrinus 13.8 65 
P. gingivalis 31.2 48 
S. mutans 40.1 55 
 
*Chlorhexidine was used as the standard drug, EOCC: Essential oil of Croton cajucara, 
MIC: Minimum inhibitory concentration.                                                                                                                             
 
5.8. Chemical composition of the various Croton species 
 
Three studies carried out by Wagate et al. 2010, Lall and Meyer, 1999 and Selowa et al. 
2010, did not provide information on the biologically active compounds responsible for the 
antibacterial activity. They mentioned, however, further studies on phytochemical analysis 
of the bioactive components of the extracts will be required. Information on the active 
compounds provided by Rodrigues et al. (2009) was based on literature. In addition to ent-
beyer-15-en-18-oic acid, derivatives such as ent-beyer-15-en-18-oic acid methyl ester; ent-
beyer-15-en-18-ol; ent-beyer-15-en-18-al; and dihydro-ent-beyer-15-en-18-ol were 
mentioned (McChesney et al. 1991). Table 15 shows the various compounds present in the 
different Croton species. 
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Table 15. Compounds present in the various Croton species  
 
Studies  Croton species  Compound(s) present  
 
Peres et al. 1999 
 
C. urucurana  
 
Acetyl aleuritic acid                                               
β-sitosterol-O-glucoside                          
Sonderianin                                          
Steroids (stigmasterol, β-
sitosterol, campesterol)                                         
Catechin                                    
Gallacatechin 
 
Abo et al. 1999 
 
C.  zambesicus  
 
Tannins                                              
Saponins                                    
Anthraquinones                              
Alkaloids 
 
McChesney et al. 1991 
 
C. sonderianus 
 
ent-Beyer-15-en-18-oic acid 
 
Alviano et al. 2005 
 
C. cajucara 
 
Linalool 
 
Shalid et al. 2008 
 
C. tiglium 
 
Proteins 
 
Rodrigues et al. 2009 
 
C. zehntneri 
 
Sesquiterpens               
Trans-Anethol                       
Trans-Caryophyllen                          
Myrcene,α-Pinene                                                                                                              
1,8-Ceneole, Estragole                                                          
Thymol, Carvacrol                                              
 
Matias et al. 2011 
 
C. campestris  
 
Tannin phlobaphenes 
Flavones  
Flavonols  
Xanthones  
Chalcones   
Aurones 
Flavononols  
Catechins  
Flavonones 
Alkaloids 
Terpenes 
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6. DISCUSSION 
 
Methanol was the most commonly used extraction solvent of Croton species against the 
various pathogenic bacteria. C. zambesicus, C. megalobotrys, C. steenkapiamus, C. 
silvaticus, C. macrostachyus and C. campestris were extracted with methanol. Ethanol was 
used with C. urucurana and C. tiglium and to extract C. sonderianus hexane was used. 
Croton pseudopulchellus was extracted using acetone and water. Essential oils were 
extracted from C. zehnteri and C. cajucara using hydrodistillation.  
Gram positive bacteria were the most commonly tested bacteria in the various experiments: 
S. aureus appeared in most of the studies. The gram negative E .coli was reported in five 
out of the ten studies used. Essential oils of C. zehntneri and hexane and methanol extracts 
of C. campestris enhanced antibiotic activity against certain Gram positive and Gram 
negative bacteria. 
The sensitivity of the studied bacteria was dependent on the Croton species used, the origin 
of the plant species, time of the collection, the storage conditions, the part of the plant 
used, the kind of the extracts used, the dose and the bacterial strain. In addition, the 
methods of the antibacterial assessment may influence on the outcome of the tests (Wagate 
et al. 2010).  
 
6.1. Gram negative bacteria and Croton extracts  
 
When hexane extracts of C. sonderianus was tested against E. coli, no activity was 
recorded. Standard antibacterial, streptomycin sulfate, produced appreciable zone of 
inhibition of 7-13 mm. In addition to acidic and neutral fractions of the hexane extracts as 
well as ent-beyer-15-en-18-oic acid obtained from acidic portion demonstrated no 
antibacterial activity against E. coli. In one study, methanol extracts of leaves and roots of 
C. macrostachyus were active against E. coli having MIC of 250 mg/ml.  
Salmonella typhimurium was resistant to aqueous extracts of C. urucurana at the MIC 
value of 5mg/ml. In addition, S. typhimurium was resistant to all extracts with the MIC 
values between 4-6 mg/ml. When S. typhimurium was tested against catechin isolated from 
ethyl acetate fraction and acetyl aleuritolic fraction derived from hexane/dichloromethane 
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fraction, MICs of 1.0 mg/ml and 0.1 mg/ml respectively were obtained. This indicated the 
inhibitory potencies of the tested compounds.                                                                                                                                         
 
When methanol extract of C. zambesicus was tested against Shigella dysenterium and 
Proteus mirabilis antibacterial activity of 10µg/ml was achieved. This activity was similar 
to the MICs produced by gentamycin and ampecillin. Tannins, saponins, anthraquinones 
and alkaloids present in the leaves and stem bark of C. zambesicus may possess the 
antibacterial activity. Essential oil of C. cajucara inhibited the growth of Porphyromonas 
gingivalis owing to the presence of linalool, although purified fraction of linalool did not 
have any inhibitory effects against P. gingivalis.                                                                  
 
Certain proteins (Ct-50) with molecular mass of 50 kDa in the crude hexane extracts and 
fractions of C. tiglium may have had inhibitory activity against Pasteurella multocida.  
While the methanol extracts of C. steenkapianus had no activity, those of C. megalobotrys 
and C. slivaticus weakly inhibited E. coli at the concentrations of 1.25mg/ml. 
Dichloromethane, ethyl acetate, acetone and methanol fractions of C. megalobotrys 
strongly inhibited E. coli at MICs ranging from 0.332-0.705 mg/ml. The n-hexane extracts 
inhibited weakly E. coli. The active compounds responsible for the inhibition E. coli had 
not been identified.   
 
6.2. Gram positive bacteria and Croton extracts  
 
Staphylococcus aureus was sensitive to aqueous ethanol extracts of C. urucurana at the 
MIC of 2.0 mg/ml. Hexane/dichloromethane fraction isolated from methanol extract had 
the MIC of 0.8mg/ml. When S. aureus was tested either to catechin purified from ethyl 
acetate fraction or to acetyl aleuritolic fraction derived from hexane/dichloromethane 
fraction, MICs of 1.0 mg/ml and 0.1 mg/ml were obtained respectively.                                                                                       
Tannins, saponins, anthraquinones, glycosides and alkaloids may have been the active 
compounds in the methanol extracts of C. zambesicus against S. aureus, M. mageterium 
and B. subtilis. This antibacterial effect was similar to that of ampicillin (10µg/ml).  
 
Methanol extracts of roots and leaves of C. macrostachyus produced some antibacterial 
activity against Bacillus cereus and Pseudomonas aeruginosa at MICs of 15.6 mg/ml and 
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250 mg/ml, respectively, but no activity was recorded against Micrococcus lutea. Hexane 
extract of C. sonderianus and its acidic and neutral fractions broadly showed inhibitory 
activities against B. subtilis, S. aureus and M. smegmatis.   Hexane extracts and the acidic 
fraction of the hexane extracts showed inhibitory activity against Pseudomonas 
aeruginosa, but not the neutral fraction and ent-beyer-15-en-18-oic acid. The compound 
ent-beyer-15-en-18-oic acid obtained from acidic portion of C. sonderianus exhibited 
strong antibacterial activity against Bacillus subtilis at the MIC value of 6.25µg/ml. 
Streptomycin had lower MIC of 3.12µg/ml, amphotericin B exhibited no activity. Croton 
cajucara essential oil inhibited all the tested bacteria: Lactobacillus casei, S. aureus, 
Streptococcus sobrinus and S. mutans. The purified linalool fraction was not effective 
against any of these bacteria.  
  
Crude hexane extracts, which were fractionated by gel filtration and ion-exchange 
chromatography form C. tiglium showed antibacterial activities of 16-25mm, 6-15mm and 
6-15mm zones of inhibition, respectively, against B. subtilis. This was due to the presence 
of antimicrobial protein (Ct-50) with estimated molecular mass of 50 kDa. Methanol 
extracts of C. steenkapianus were inactive against S. aureus and Enterococcus faecalis, but 
active against P. aeruginosa at the MIC of 0.625 mg/ml. C. silvaticus methanol extracts 
weakly inhibited all the tested Gram positive bacteria: S. aureus, E. faecalis, P. aeruginosa 
at the constant MIC of 1.25 mg/ml. C. megalobotrys methanol extracts inhibited S. aureus 
and P. aeruginosa at the MICs of 0.625 mg/ml and 0.313 mg/ml, respectively. C. 
megalobotrys methanol extracts were effective inhibitors against E. faecalis at the MIC of 
0.02 mg/ml. 
  
Dichloromethane, ethyl acetate, acetone, methanol and n-hexane fractions of C. 
megalobotrys inhibited strongly E. faecalis and P. aeruginosa at the MICs between 0.120-
0.276 mg/ml and 0.060-0322mg/ml, respectively. Dichloromethane, ethyl acetate, acetone 
and methanol fractions of C. megalobotrys had remarkable inhibitory activity against S. 
aureus at MICs ranging from 0.236-0.468 mg/ml but n-hexane extracts were weak against 
S. aureus at the MIC of 1.562 mg/ml. 
 
Volatile compounds of Croton zehntneri essential oils (CZEO) were tested against P. 
aeruginosa. The bacteria were less susceptible owing to growth of the bacteria at all the 
concentrations ranging from 1-0.031 mg/L air. CZEO inhibited the growth of S. aureus at 
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the concentrations of 1 and 0.5 mg/L air. One possible mechanism of action of CZEO is 
the disruption of the enzymatic activity of the bacterial cell (Wendakoon and Sakaguchi 
1995). 
 
6.3. Other forms of bacteria and extracts of Croton  
 
Acetone extracts of Croton pseudopulchellus were tested against sensitive strain (H37Rv) 
of Mycobacterium tuberculosis. The MIC value of the acetone extract of C. 
pseudopulchellus was 0.5 mg/ml in the agar plate method, but the water extract of C. 
pseudopulchellus did not produce any activity. Nonpolar active compounds may not have 
been present in the water extracts of C. pseudopulchellus. In addition, instead of using the 
aerial portions of the plant, the roots should have been taken for the study. Acetone 
extracts of C. pseudopulchellus inhibited both the sensitive (H37Rv) and resistant 
(CCKO28469V) strains of M. tuberculosis at MICs of 0.1mg/ml and 0.5mg/ml, 
respectively when the radiometric method was used. Radiometric method produces results 
faster than plate method because cell-to-drug interactions occur faster. In addition, test 
compounds are unlikely to breakdown because of the reduced incubation time (Lall and 
Meyer 1999). 
 
6.4. Antibiotic modifying activity of Croton extracts  
 
Two antibiotics, gentamicin and tetracycline, were tested against P. aeruginosa alone or 
together with a volatile component of the essential oil of C. zehntneri (EOCZ). No 
significant activity was recorded for the tetracycline EOCZ combination. EOCZ enhanced 
the activity of gentamicin by 42.8%. The hydrophobic nature of essential oils disrupted 
respiratory activities and energy production line of the bacterial cells. They affected on the 
plasma membrane in general making the bacterial cells more permeable to antibiotics. 
Essential oils can be used in combination with antibiotics for effective treatment of certain 
bacterial infections (Burt 2004, Juven et al. 1998).  
Hexane extracts of C. campestris (HECC) and methanol extracts of C. campestris (MECC) 
enhanced the antibiotic activity of gentamicin, kanamycin and amikacin when tested 
against E. coli and S. aureus at subinhibitory concentrations of 8µg/ml. HECC exhibited 
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synergy when combined with gentamicin, kanamycin and amikacin against E. coli. MECC 
was effective against E. coli, when combined with gentamicin and amikacin, but 
combination with kanamycin was not effective. Against S. aureus, both extracts and all the 
antibiotics proved effective (Matias et al. 2010). The mechanism behind the synergistic 
effect may due to the presence of tannins, flavonols and terpenes in C. campestris non 
polar extracts (methanol and hexane). Tannins are known to provide natural defense 
against microbial infections (Ho et al. 2001), and they can be used to prevent bacterial 
infections. In response to microbial infections, plant flavonoids form complexes with 
bacterial cell proteins and interfere with the cell‟s activities in the process of bacterial 
adhesion. Actions of some flavanoids may result in the rupture of bacterial plasma 
membrane (Tsuchiya et al. 1996). Terpene antibacterial activities appear in different forms: 
sesquiterpenes, tetraterpenes, diterpenes or triterpenes (Ahamd et al. 1993).                                                
 
6.5. Further research implications 
 
In order to carry out detailed characterization of the bioactive compounds from the C. 
megalobotrys, C. steenkapiannus, C. silvaticus, C. pseudopulchellus and C. macrostachyus 
species, further work will be needed. Animal models will be required to study in vivo 
activities of the extracts of the active Croton plants. The active biological agents should be 
tested as regards to their pharmacological applicability. Toxicity studies should also be 
carried out for all the extracts and fractions. Further, studies on the synergistic relationship 
between other Croton extracts and synthetic antibiotic drugs will be required in the future. 
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7. CONCLUSIONS  
 
This review evaluated the antibacterial properties of Croton species based on relevant 
research reports from 1990 to 2011. Organic extracts of Croton species inhibited both 
Gram positive and Gram negative bacteria. Inorganic extracts were ineffective but acetone 
extracts inhibited the growth of the antibiotic sensitive strain of M. tuberculosis. When the 
radiometric method was used both the sensitive and resistant strains of M. tuberculosis 
were inhibited by the acetone extracts. Essential oil obtained by hydro-distillation inhibited 
some strains of the studied bacteria and enhanced the effect of some of the antibiotics used 
in the studies. The results show that the extracts of Croton species could be used as 
alternative means in pharmacotherapy of bacterial infections.  They could be also used as 
adjuvant agents in antibiotic therapy against pathogenic bacterial infections. 
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